Pacific Biosciences of California, Inc. (PACB)
Largest Insider Buys in Sector
PACB Stock Price History Chart
PACB Stock Performance
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Insider Activity of Pacific Biosciences of California, Inc.
Over the last 12 months, insiders at Pacific Biosciences of California, Inc. have bought $176,160 and sold $3.48M worth of Pacific Biosciences of California, Inc. stock.
On average, over the past 5 years, insiders at Pacific Biosciences of California, Inc. have bought $176,160 and sold $49.77M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Meline David W (director) — $528,480.
The last purchase of 40,000 shares for transaction amount of $176,160 was made by Meline David W (director) on 2024‑03‑06.
List of Insider Buy and Sell Transactions, Pacific Biosciences of California, Inc.
| 2024-05-20 | Sale | Farmer Michele | See Remarks | 5,275 0.002% | $2.03 | $10,708 | -4.17% | |
| 2024-03-06 | Meline David W | director | 40,000 0.0158% | $4.40 | $176,160 | -53.71% | ||
| 2024-03-04 | Sale | HENRY CHRISTIAN O | See Remarks | 14,177 0.0053% | $4.87 | $69,056 | -60.25% | |
| 2024-03-04 | Sale | Van Oene Mark | See Remarks | 9,186 0.0034% | $4.87 | $44,745 | -60.25% | |
| 2024-03-04 | Sale | Kim Susan G. | See Remarks | 5,275 0.002% | $4.87 | $25,695 | -60.25% | |
| 2024-03-04 | Sale | Farmer Michele | See Remarks | 2,968 0.0011% | $4.87 | $14,457 | -60.25% | |
| 2024-02-20 | Sale | HENRY CHRISTIAN O | See Remarks | 1,979 0.0007% | $5.26 | $10,412 | -61.81% | |
| 2024-02-20 | Sale | Kim Susan G. | See Remarks | 831 0.0003% | $5.26 | $4,372 | -61.81% | |
| 2024-02-16 | Sale | HENRY CHRISTIAN O | See Remarks | 79,038 0.0307% | $5.96 | $470,908 | -64.63% | |
| 2024-02-16 | Sale | Van Oene Mark | See Remarks | 33,560 0.013% | $5.96 | $199,950 | -64.63% | |
| 2024-02-16 | Sale | Eidel Jeff | See Remarks | 15,498 0.006% | $5.96 | $92,337 | -64.63% | |
| 2024-02-16 | Sale | Kim Susan G. | See Remarks | 22,496 0.0087% | $5.96 | $134,031 | -64.63% | |
| 2024-02-16 | Sale | Farmer Michele | See Remarks | 7,562 0.0029% | $5.96 | $45,054 | -64.63% | |
| 2024-01-09 | Sale | Van Oene Mark | See Remarks | 31,012 0.0117% | $7.77 | $241,056 | -55.11% | |
| 2023-12-14 | Sale | HENRY CHRISTIAN O | See Remarks | 20,000 0.0076% | $10.00 | $200,000 | -62.12% | |
| 2023-09-29 | Sale | Kim Susan G. | See Remarks | 19,257 0.0078% | $8.44 | $162,471 | -26.44% | |
| 2023-09-18 | Sale | HENRY CHRISTIAN O | See Remarks | 96,844 0.0404% | $10.12 | $980,255 | -33.47% | |
| 2023-09-11 | Sale | HENRY CHRISTIAN O | See Remarks | 10,000 0.004% | $10.45 | $104,520 | -37.33% | |
| 2023-08-17 | Sale | HENRY CHRISTIAN O | See Remarks | 10,000 0.004% | $10.50 | $105,000 | -36.69% | |
| 2023-08-17 | Sale | Eidel Jeff | See Remarks | 25,936 0.0105% | $10.60 | $274,844 | -36.69% |
Insider Historical Profitability
| HENRY CHRISTIAN O | See Remarks | 2596670 0.4061% | $1.36 | 0 | 12 | |
| Van Oene Mark | See Remarks | 1668826 0.3403% | $1.36 | 0 | 7 | |
| Eidel Jeff | See Remarks | 431824 0.1663% | $1.36 | 0 | 2 | |
| Kim Susan G. | See Remarks | 712260 0.1144% | $1.36 | 0 | 9 | |
| Farmer Michele | See Remarks | 211941 0.0402% | $1.36 | 0 | 6 | |
| Meline David W | director | 40000 0.0149% | $1.36 | 1 | 0 | |
| Turner Stephen W | VP & Chief Technology Officer | 1025163 0.3833% | $1.36 | 0 | 3 | |
| BARNES SUSAN K | EVP, CFO and PAO | 874812 0.3271% | $1.36 | 0 | 2 | |
| Hunkapiller Michael | director | 848405 0.3172% | $1.36 | 20 | 28 | +56.73% |
| Phillips James Michael | SVP, Research & Development | 249220 0.0932% | $1.36 | 8 | 7 | +5.88% |
| Fromen Peter | Chief Commercial Officer | 140280 0.0525% | $1.36 | 0 | 1 | |
| Schaefer Eric | Chief Accounting Officer | 88474 0.0331% | $1.36 | 0 | 1 | |
| CORCORAN KEVIN P | SVP, Market Development | 40455 0.0151% | $1.36 | 3 | 0 | <0.0001% |
| ORDONEZ KATHY | director | 18595 0.007% | $1.36 | 0 | 4 | |
| Ericson William W. | director | 18795 0.007% | $1.36 | 12 | 2 | +17.15% |
| Dow Brian B | VP and PAO | 18119 0.0068% | $1.36 | 1 | 0 | <0.0001% |
| Shapiro Lucy | director | 0 0% | $1.36 | 0 | 1 | |
| Botstein David | director | 0 0% | $1.36 | 0 | 1 | |
| LIVINGSTON RANDALL S | director | 0 0% | $1.36 | 0 | 1 |
Institutional Investor Ownership
| ARK Investment Management LLC | $124.84M | 12.22 | 33.29M | -3.52% | -$4.55M | 0.87 | |
| The Vanguard Group | $99.77M | 9.77 | 26.61M | -0.68% | -$686,501.24 | <0.01 | |
| BlackRock | $87.73M | 8.59 | 23.39M | -5.06% | -$4.68M | <0.01 | |
| Madrone Advisors Llc | $65.97M | 6.46 | 17.59M | 0% | +$0 | 9.04 | |
| Sumitomo Mitsui Trust Holdings | $48.09M | 4.71 | 12.82M | -2.85% | -$1.41M | 0.03 | |
| Nikko Asset Management Americas Inc | $47.96M | 4.71 | 12.82M | -2.85% | -$1.41M | 0.46 | |
| BNY Mellon | $42.66M | 4.18 | 11.38M | +132.51% | +$24.31M | 0.01 | |
| Edmond De Rothschild Holding S A | $39.4M | 3.86 | 10.51M | +955.48% | +$35.67M | 0.17 | |
| T Rowe Price Investment Management Inc | $31.49M | 3.08 | 8.4M | +8.31% | +$2.42M | 0.02 | |
| Jackson Square LLC | $26.94M | 2.64 | 7.18M | -25.97% | -$9.45M | 1.12 | |
| Deep Track Capital Lp | $26.25M | 2.57 | 7M | 0% | +$0 | 0.12 | |
| Macquarie Group | $24.9M | 2.44 | 6.64M | +33.54% | +$6.25M | 0.02 | |
| State Street | $21.63M | 2.12 | 5.77M | +2.57% | +$542,092.49 | <0.01 | |
| Geode Capital Management | $21.16M | 2.07 | 5.64M | +2.29% | +$474,046.16 | <0.01 | |
| Bellevue Group | $17.22M | 1.69 | 4.59M | -37.24% | -$10.22M | 0.26 | |
| Farallon Capital | $14.15M | 1.39 | 3.77M | -39.07% | -$9.07M | 0.1 | |
| Dimensional Fund Advisors | $12.88M | 1.26 | 3.43M | +12.34% | +$1.41M | <0.01 | |
| Capital World Investors | $12.71M | 1.25 | 3.39M | 0% | +$0 | <0.01 | |
| Capital International Investors | $11.68M | 1.14 | 3.11M | 0% | +$0 | <0.01 | |
| Vk Services Llc | $9.87M | 0.97 | 2.63M | 0% | +$0 | 1.8 | |
| Northern Trust | $9.54M | 0.93 | 2.54M | -5.74% | -$580,485.02 | <0.01 | |
| Millennium Management LLC | $9.05M | 0.89 | 2.41M | New | +$9.05M | 0.01 | |
| Goldman Sachs | $8.27M | 0.81 | 2.21M | +38.65% | +$2.31M | <0.01 | |
| Eagle Health Investments Lp | $8.13M | 0.8 | 2.17M | +42.31% | +$2.42M | 1.55 | |
| Charles Schwab | $7.45M | 0.73 | 1.99M | +1.05% | +$77,557.50 | <0.01 | |
| T. Rowe Price | $7.33M | 0.72 | 1.96M | -45.67% | -$6.17M | <0.01 | |
| Morgan Stanley | $7.14M | 0.7 | 1.9M | -82.87% | -$34.53M | <0.01 | |
| Qube Research & Technologies | $6.71M | 0.66 | 1.79M | New | +$6.71M | 0.01 | |
| Soros Fund Management | $6.12M | 0.6 | 1.63M | New | +$6.12M | 0.25 | |
| Bank of America | $6M | 0.59 | 1.6M | +94.3% | +$2.91M | <0.01 | |
| SEI Investments Company | $5.84M | 0.57 | 1.56M | -15.35% | -$1.06M | 0.01 | |
| Woodline Partners LP | $5.77M | 0.56 | 1.54M | -17.08% | -$1.19M | 0.06 | |
| Citadel Advisors LLC | $5.56M | 0.54 | 1.48M | +172.23% | +$3.52M | <0.01 | |
| Oracle Investment Management Inc | $5.09M | 0.5 | 1.36M | -1.51% | -$77,883.76 | 0.69 | |
| Mirae Asset Global Investments Co Ltd | $12.15M | 0.49 | 1.34M | +44.11% | +$3.72M | 0.01 | |
| Casdin Capital | $3.88M | 0.38 | 1.04M | 0% | +$0 | 0.29 | |
| Vestmark Advisory Solutions Inc | $3.51M | 0.34 | 935,289 | +89.03% | +$1.65M | 0.2 | |
| Hillhouse Capital Advisors Ltd | $3.45M | 0.34 | 918,892 | 0% | +$0 | 0.08 | |
| JPMorgan Chase | $3.23M | 0.32 | 861,393 | -32.88% | -$1.58M | <0.0001 | |
| Fidelity Investments | $3.2M | 0.31 | 852,907 | -77.1% | -$10.77M | <0.0001 | |
| D. E. Shaw & Co. | $3.03M | 0.3 | 809,260 | +7,355.18% | +$2.99M | <0.01 | |
| Senvest Management Llc | $2.6M | 0.26 | 694,554 | New | +$2.6M | 0.1 | |
| Nuveen | $2.55M | 0.25 | 679,926 | +2.12% | +$52,953.76 | <0.01 | |
| UBS | $2.54M | 0.25 | 677,253 | +1,898.15% | +$2.41M | <0.01 | |
| Avidity Partners Management Lp | $2.53M | 0.25 | 675,000 | New | +$2.53M | 0.09 | |
| Barclays | $2.49M | 0.24 | 665,077 | +42.77% | +$747,089.64 | <0.01 | |
| Bourne Lent Asset Management Inc | $2.45M | 0.24 | 654,415 | +10.5% | +$233,249.98 | 0.99 | |
| Td Asset Management Inc | $2M | 0.2 | 533,500 | -19.33% | -$479,250.00 | <0.01 | |
| Susquehanna International Group | $1.99M | 0.19 | 529,616 | -30.87% | -$887,058.75 | <0.01 | |
| Jane Street Capital | $1.95M | 0.19 | 520,811 | +6.9% | +$126,097.55 | <0.01 |